News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ZenBio, Inc. Awarded a Phase I SBIR Grant to Develop Novel Human Cell-Based Models of Fatty Liver Disease


4/21/2010 11:55:11 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells. The current award from the National Institutes of Health will fund proof-of-concept studies that these human hepatocyte-like cells can be used to mimic the development of non-alcoholic fatty liver disease in cell culture.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES